Enhancing remyelination in disease - Can we wrap it up?

Brain

Volumn 134, Issue 7, 2011, Pages 1882-1900

  Kotter, Mark R ^a   Stadelmann, Christine ^b   Hartung, Hans Peter ^c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

multiple sclerosis; myelin; Neural stem cells; oligodendrocyte precursor cell; remyelination

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; HYALURONIC ACID; JAGGED1; MEMBRANE PROTEIN; NERVE CELL ADHESION MOLECULE; NOGGIN; NOTCH1 RECEPTOR; OSTEOGENIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; POLYSIALYLATED NERVE CELL ADHESION MOLECULE; PROTEIN LINGO 1; SEMAPHORIN 3A; SEMAPHORIN 3F; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR 7 LIKE 2; TRANSCRIPTION FACTOR NKX2.2; UNCLASSIFIED DRUG; WNT2 PROTEIN; WNT3A PROTEIN; WNT7A PROTEIN;

AUTOPSY; BRAIN BIOPSY; CELL DIFFERENTIATION; CELL INTERACTION; CELL LINEAGE; CELL MATURATION; CENTRAL NERVOUS SYSTEM; DEMYELINATING DISEASE; HUMAN; IMMUNOMODULATION; INFLAMMATION; MACROGLIA; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE FIBER REGENERATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMYELINIZATION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM; DEMYELINATING DISEASES; HUMANS; HYALURONIC ACID; MODELS, BIOLOGICAL; MYELIN SHEATH; OLIGODENDROGLIA; REGENERATION; SEMAPHORIN-3A; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 79959744924     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awr014     Document Type: Review

References (164)

1. Achiron A, Gabbay U, Gilad R, Hassin-Baer S, Barak Y, Gornish M, et al. Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses. Neurology 1998; 50: 398-402.
2. Androdias G, Reynolds R, Chanal M, Ritleng C, Confavreux C, Nataf S. Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords. Ann Neurol 2010; 68: 465-76.
3. Ara J, See J, Mamontov P, Hahn A, Bannerman P, Pleasure D, et al. Bone morphogenetic proteins 4, 6, and 7 are up-regulated in mouse spinal cord during experimental autoimmune encephalomyelitis. J Neurosci Res 2008; 86: 125-35.
4. Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting JP. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci 2001; 4: 1116-22. (Pubitemid 34116557)
5. Arnett HA, Wang Y, Matsushima GK, Suzuki K, Ting JP. Functional gen-omic analysis of remyelination reveals importance of inflammation in oligodendrocyte regeneration. J Neurosci 2003; 23: 9824-32. (Pubitemid 37371596)
6. Back SA, Tuohy TM, Chen H, Wallingford N, Craig A, Struve J, et al. Hyaluronan accumulates in demyelinated lesions and inhibits oligo-dendrocyte progenitor maturation. Nat Med 2005; 11: 966-72. (Pubitemid 41294442)
7. Baer AS, Syed YA, Kang SU, Mitteregger D, Vig R, ffrench-Constant C, et al. Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling. Brain 2009; 132(Pt 2): 465-81.
8. Bansal R, Warrington AE, Gard AL, Ranscht B, Pfeiffer SE. Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development. J Neurosci Res 1989; 24: 548-57. (Pubitemid 20015347)
9. Barres BA, Hart IK, Coles HS, Burne JF, Voyvodic JT, Richardson WD, et al. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 1992; 70: 31-46.
10. Belachew S, Chittajallu R, Aguirre AA, Yuan X, Kirby M, Anderson S, et al. Postnatal NG2 proteoglycan-expressing progenitor cells are intrinsically multipotent and generate functional neurons. J Cell Biol 2003; 161: 169-86. (Pubitemid 36459089)
11. Bieber AJ, Kerr S, Rodriguez M. Efficient central nervous system remye-lination requires T cells. Ann Neurol 2003; 53: 680-4. (Pubitemid 36529446)
12. Blaschuk KL, Frost EE, Ffrench-Constant C. The regulation of proliferation and differentiation in oligodendrocyte progenitor cells by alphaV in-tegrins. Development 2000; 127: 1961-9. (Pubitemid 30311799)
13. Bruck W, Bruck Y, Friede RL. TNF-alpha suppresses CR3-mediated myelin removal by macrophages. J Neuroimmunol 1992; 38: 9-17.
14. Bruck W, Porada P, Poser S, Rieckmann P, Hanefeld F, Kretzschmar HA, et al. Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann Neurol 1995; 38: 788-96.
15. Buttery PC, Ffrench-Constant C. Laminin-2/integrin interactions enhance myelin membrane formation by oligodendrocytes. Mol Cell Neurosci 1999; 14: 199-212. (Pubitemid 29449223)
16. Cassiani-Ingoni R, Coksaygan T, Xue H, Reichert-Scrivner SA, Wiendl H, Rao MS, et al. Cytoplasmic translocation of Olig2 in adult glial progenitors marks the generation of reactive astrocytes following autoimmune inflammation. Exp Neurol 2006; 201: 349-58. (Pubitemid 44344228)
17. Chang A, Nishiyama A, Peterson J, Prineas J, Trapp BD. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 2000; 20: 6404-12.
18. Chang A, Tourtellotte WW, Rudick R, Trapp BD. Premyelinating oligo-dendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 2002; 346: 165-73. (Pubitemid 34438882)
19. Chari DM, Zhao C, Kotter MR, Blakemore WF, Franklin RJ. Corticosteroids delay remyelination of experimental demyelination in the rodent central nervous system. J Neurosci Res 2006; 83: 594-605. (Pubitemid 43384853)
20. Charles P, Hernandez MP, Stankoff B, Aigrot MS, Colin C, Rougon G, et al. Negative regulation of central nervous system myelination by polysialylated-neural cell adhesion molecule. Proc Natl Acad Sci USA 2000; 97: 7585-90. (Pubitemid 30431507)
21. Charles P, Reynolds R, Seilhean D, Rougon G, Aigrot MS, Niezgoda A, et al. Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis? Brain 2002; 125 (Pt 9): 1972-9.
22. Chen Y, Miles DK, Hoang T, Shi J, Hurlock E, Kernie SG, et al. The basic helix-loop-helix transcription factor olig2 is critical for reactive astro-cyte proliferation after cortical injury. J Neurosci 2008; 28: 10983-9.
23. Cheng X, Wang Y, He Q, Qiu M, Whittemore SR, Cao Q. Bone mor-phogenetic protein signaling and olig1/2 interact to regulate the differentiation and maturation of adult oligodendrocyte precursor cells. Stem Cells 2007; 25: 3204-14. (Pubitemid 350294446)
24. Chien AJ, Conrad WH, Moon RT. A Wnt survival guide: from flies to human disease. J Invest Dermatol 2009; 129: 1614-27.
25. Ciric B, Van KV, Paz SM, Rodriguez M, Pease LR. Antibody-mediated remyelination operates through mechanism independent of immuno-modulation. J Neuroimmunol 2004; 146: 153-61. (Pubitemid 38032967)
26. Cohen RI, Rottkamp DM, Maric D, Barker JL, Hudson LD. A role for semaphorins and neuropilins in oligodendrocyte guidance. J Neurochem 2003; 85: 1262-78. (Pubitemid 36613274)
27. Colognato H, Ramachandrappa S, Olsen IM, Ffrench-Constant C. Integrins direct Src family kinases to regulate distinct phases of oligo-dendrocyte development. J Cell Biol 2004; 167: 365-75. (Pubitemid 39435078)
28. Crawford DK, Mangiardi M, Song B, Patel R, Du S, Sofroniew MV, et al. Oestrogen receptor {beta} ligand: a novel treatment to enhance endogenous functional remyelination. Brain 2010; 133(Pt 10): 2999-3016.
29. D'Souza B, Miyamoto A, Weinmaster G. The many facets of Notch ligands. Oncogene 2008; 27: 5148-67.
30. De Winter F, Holtmaat AJ, Verhaagen J. Neuropilin and class 3 sema-phorins in nervous system regeneration. Adv Exp Med Biol 2002; 515: 115-39. (Pubitemid 36324186)
31. Dugas JC, Ibrahim A, Barres BA. A crucial role for p57(Kip2) in the intracellular timer that controls oligodendrocyte differentiation. J Neurosci 2007; 27: 6185-96. (Pubitemid 46890015)
32. Fancy SP, Zhao C, Franklin RJM. Increased expression of Nkx2.2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS. Mol Cell Neurosci 2004; 27: 247-54. (Pubitemid 39433839)
33. Fancy SPJ, Baranzini SE, Zhao C, Yuk D-I, Irvine K-A, Kaing S, et al. Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev 2009; 23: 1571-85.
34. Fazekas F, Deisenhammer F, Strasser-Fuchs S, Nahler G, Mamoli B. Randomised placebo-controlled trial of monthly intravenous immuno-globulin therapy in relapsing-remitting multiple sclerosis. Austrian Immunoglobulin in Multiple Sclerosis Study Group. Lancet 1997; 349: 589-93. (Pubitemid 27101884)
35. Fazekas F, Lublin FD, Li D, Freedman MS, Hartung HP, Rieckmann P, et al. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial. Neurology 2008; 71: 265-71.
36. Foote AK, Blakemore WF. Inflammation stimulates remyelination in areas of chronic demyelination. Brain 2005; 128 (Pt 3): 528-39. (Pubitemid 40380188)
37. Franklin RJ. Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 2002; 3: 705-14. (Pubitemid 135706676)
38. Franklin RJ, Bayley SA, Milner R, Ffrench-Constant C, Blakemore WF. Differentiation of the O-2A progenitor cell line CG-4 into oligodendro-cytes and astrocytes following transplantation into glia-deficient areas of CNS white matter. Glia 1995; 13: 39-44.
39. Franklin RJ, Ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 2008; 9: 839-55.
40. Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M, et al. The relation between inflammation and neuro-degeneration in multiple sclerosis brains. Brain 2009; 132 (Pt 5): 1175-89.
41. Frohman EM, Racke MK, Raine CS. Multiple sclerosis-the plaque and its pathogenesis. N Engl J Med 2006; 354: 942-55.
42. Fukuda S, Kondo T, Takebayashi H, Taga T. Negative regulatory effect of an oligodendrocytic bHLH factor OLIG2 on the astrocytic differentiation pathway. Cell Death Differ 2004; 11: 196-202. (Pubitemid 38159643)
43. Fuller ML, DeChant AK, Rothstein B, Caprariello A, Wang R, Hall AK, et al. Bone morphogenetic proteins promote gliosis in demyelinating spinal cord lesions. Ann Neurol 2007; 62: 288-300. (Pubitemid 47525405)
44. Gabay L, Lowell S, Rubin LL, Anderson DJ. Deregulation of dorsoventral patterning by FGF confers trilineage differentiation capacity on CNS stem cells in vitro. Neuron 2003; 40: 485-99. (Pubitemid 37494699)
45. Gard AL, Burrell MR, Pfeiffer SE, Rudge JS, Williams WC. Astroglial control of oligodendrocyte survival mediated by PDGF and leukemia inhibitory factor-like protein. Development 1995; 121: 2187-97.
46. Ghiani CA, Eisen AM, Yuan X, DePinho RA, McBain CJ, Gallo V. Neurotransmitter receptor activation triggers p27(Kip1) and p21 (CIP1) accumulation and G1 cell cycle arrest in oligodendrocyte progenitors. Development 1999; 126: 1077-90. (Pubitemid 29142014)
47. Godfraind C, Friedrich VL, Holmes KV, Dubois-Dalcq M. In vivo analysis of glial cell phenotypes during a viral demyelinating disease in mice. J Cell Biol 1989; 109: 2405-16. (Pubitemid 19282625)
48. Goldschmidt T, Antel J, Konig FB, Bruck W, Kuhlmann T. Remyelination capacity of the MS brain decreases with disease chronicity. Neurology 2009; 72: 1914-21.
49. Gomes WA, Mehler MF, Kessler JA. Transgenic overexpression of BMP4 increases astroglial and decreases oligodendroglial lineage commitment. Dev Biol 2003; 255: 164-77. (Pubitemid 36287148)
50. Gottle P, Kremer D, Jander S, Odemis V, Engele J, Hartung HP, et al. Activation of CXCR7 Receptor Promotes Oligodendroglial Cell Maturation. Ann Neurol 2010; 68: 915-24.
51. Griffiths I, Klugmann M, Anderson T, Yool D, Thomson C, Schwab MH, et al. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 1998; 280: 1610-3. (Pubitemid 28278256)
52. Gutowski NJ, Newcombe J, Cuzner ML. Tenascin-R and C in multiple sclerosis lesions: relevance to extracellular matrix remodelling. Neuropathol Appl Neurobiol 1999; 25: 207-14. (Pubitemid 29313225)
53. Hampton DW, Asher RA, Kondo T, Steeves JD, Ramer MS, Fawcett JW. A potential role for bone morphogenetic protein signalling in glial cell fate determination following adult central nervous system injury in vivo. Eur J Neurosci 2007; 26: 3024-35. (Pubitemid 350135185)
54. Hinks GL, Franklin RJM. Distinctive patterns of PDGF-A, FGF-2, IGF-I, and TGF-beta1 gene expression during remyelination of experimentally-induced spinal cord demyelination. Mol Cell Neurosci 1999; 14: 153-68. (Pubitemid 29444885)
55. Hinks GL, Franklin RJM. Delayed changes in growth factor gene expression during slow remyelination in the CNS of aged rats. Mol Cell Neurosci 2000; 16: 542-56. (Pubitemid 32001304)
56. Hommes OR, Sorensen PS, Fazekas F, Enriquez MM, Koelmel HW, Fernandez O, et al. Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial. Lancet 2004; 364: 1149-56. (Pubitemid 39296602)
57. Horwitz MS, Evans CF, McGavern DB, Rodriguez M, Oldstone MB. Primary demyelination in transgenic mice expressing interferon-gamma. Nat Med 1997; 3: 1037-41. (Pubitemid 27391963)
58. Howe CL, Bieber AJ, Warrington AE, Pease LR, Rodriguez M. Antiapoptotic signaling by a remyelination-promoting human antimye-lin antibody. Neurobiol Dis 2004; 15: 120-31. (Pubitemid 38134387)
59. Hughes SM, Lillien LE, Raff MC, Rohrer H, Sendtner M. Ciliary neuro-trophic factor induces type-2 astrocyte differentiation in culture. Nature 1988; 335: 70-3.
60. Inestrosa NC, Arenas E. Emerging roles of Wnts in the adult nervous system. Nat Rev Neurosci 2010; 11: 77-86.
61. Irvine KA, Blakemore WF. Remyelination protects axons from demyelination-associated axon degeneration. Brain 2008; 131(Pt 6): 1464-77. (Pubitemid 351806463)
62. Ji JD, Park-Min KH, Ivashkiv LB. Expression and function of semaphorin 3A and its receptors in human monocyte-derived macrophages. Hum Immunol 2009; 70: 211-7.
63. John GR, Shankar SL, Shafit-Zagardo B, Massimi A, Lee SC, Raine CS, et al. Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat Med 2002; 8: 1115-21. (Pubitemid 35175966)
64. Jurynczyk M, Jurewicz A, Bielecki B, Raine CS, Selmaj K. Inhibition of Notch signaling enhances tissue repair in an animal model of multiple sclerosis. J Neuroimmunol 2005; 170: 3-10. (Pubitemid 41740902)
65. Juryńczyk M, Selmaj K. Notch: a new player in MS mechanisms. J Neuroimmunol 2010; 218 :3-11.
66. Kantarci OH, Hebrink DD, Schaefer-Klein J, Sun Y, Achenbach S, Atkinson EJ, et al. Interferon gamma allelic variants: sex-biased multiple sclerosis susceptibility and gene expression. Arch Neurol 2008; 65: 349-57. (Pubitemid 351398520)
67. Kippert A, Fitzner D, Helenius J, Simons M. Actomyosin contractility controls cell surface area of oligodendrocytes. BMC Cell Biol 2009; 10: 71.
68. Kondo T, Raff MC. A role for Noggin in the development of oligo-dendrocyte precursor cells. Dev Biol 2004; 267: 242-51. (Pubitemid 38234747)
69. Kotter MR, Li WW, Zhao C, Franklin RJM. Myelin impairs CNS remye-lination by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci 2006; 26: 328-32. (Pubitemid 43089546)
70. Kotter MR, Setzu A, Sim FJ, Van Rooijen N, Franklin RJM. Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination. Glia 2001; 35: 204-12. (Pubitemid 32827763)
71. Kotter MR, Zhao C, Van Rooijen N, Franklin RJM. Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Neurobiol Dis 2005; 18: 166-75. (Pubitemid 40092906)
72. Koutsoudaki PN, Hildebrandt H, Gudi V, Skripuletz T, Skuljec J, Stangel M. Remyelination after cuprizone induced demyelination is accelerated in mice deficient in the polysialic acid synthesizing enzyme St8siaIV. Neuroscience 2010.
73. Kremer D, Heinen A, Jadasz J, Gottle P, Zimmermann K, Zickler P, et al. p57kip2 is dynamically regulated in experimental autoimmune enceph-alomyelitis and interferes with oligodendroglial maturation. Proc Natl Acad Sci USA 2009; 106: 9087-92.
74. Kuhlmann T, Miron V, Cuo Q, Wegner C, Antel J, Bruck W. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 2008; 131(Pt 7): 1749-58. (Pubitemid 351957453)
75. Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, Braun PE, et al. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 2003; 33: 366-74. (Pubitemid 36278853)
76. Lassmann H, Bruck W, Lucchinetti C. Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med 2001; 7: 115-21. (Pubitemid 32201673)
77. Lazarov-Spiegler O, Solomon AS, Schwartz M. Peripheral nerve-stimulated macrophages simulate a peripheral nerve-like regenerative response in rat transected optic nerve. Glia 1998; 24: 329-37. (Pubitemid 28465980)
78. Li C, Tropak MB, Gerlai R, Clapoff S, Abramow-Newerly W, Trapp B, et al. Myelination in the absence of myelin-associated glycoprotein. Nature 1994; 369: 747-50. (Pubitemid 24225364)
79. Lillien LE, Sendtner M, Raff MC. Extracellular matrix-associated molecules collaborate with ciliary neurotrophic factor to induce type-2 astrocyte development. J Cell Biol 1990; 111: 635-44.
80. Lingor P, Teusch N, Schwarz K, Mueller R, Mack H, Bahr M, et al. Inhibition of Rho kinase (ROCK) increases neurite outgrowth on chon-droitin sulphate proteoglycan in vitro and axonal regeneration in the adult optic nerve in vivo. J Neurochem 2007; 103: 181-9. (Pubitemid 47404219)
81. Linker R, Gold R, Luhder F. Function of neurotrophic factors beyond the nervous system: inflammation and autoimmune demyelination. Crit Rev Immunol 2009; 29: 43-68.
82. Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 2002; 8: 500-8. (Pubitemid 34546753)
83. Lu HZ, Wang YX, Zou J, Li Y, Fu SL, Jin JQ, et al. Differentiation of neural precursor cell-derived oligodendrocyte progenitor cells following transplantation into normal and injured spinal cords. Differentiation 2010; 80: 228-40.
84. Lubetzki C, Goujet-Zalc C, Demerens C, Danos O, Zalc B. Clonal segregation of oligodendrocytes and astrocytes during in vitro differentiation of glial progenitor cells. Glia 1992; 6: 289-300.
85. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 1999; 122 (Pt 12): 2279-95.
86. Mabie PC, Mehler MF, Marmur R, Papavasiliou A, Song Q, Kessler JA. Bone morphogenetic proteins induce astroglial differentiation of oligodendroglial- astroglial progenitor cells. J Neurosci 1997; 17: 4112-20. (Pubitemid 27220602)
87. Magnus T, Coksaygan T, Korn T, Xue H, Arumugam TV, Mughal MR, et al. Evidence that nucleocytoplasmic Olig2 translocation mediates brain-injury-induced differentiation of glial precursors to astrocytes. J Neurosci Res 2007; 85: 2126-37. (Pubitemid 47172144)
88. Marin-Husstege M, Muggironi M, Liu A, Casaccia-Bonnefil P. Histone deacetylase activity is necessary for oligodendrocyte lineage progression. J Neurosci 2002; 22: 10333-45. (Pubitemid 35416871)
89. Marin-Husstege M, Muggironi M, Raban D, Skoff RP, Casaccia-Bonnefil P. Oligodendrocyte progenitor proliferation and maturation is differentially regulated by male and female sex steroid hormones. Dev Neurosci 2004; 26: 245-54. (Pubitemid 40867979)
90. Mason JL, Suzuki K, Chaplin DD, Matsushima GK. Interleukin-1beta promotes repair of the CNS. J Neurosci 2001; 21: 7046-52.
91. Mason JL, Xuan S, Dragatsis I, Efstratiadis A, Goldman JE. Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays an important role in remyelination. J Neurosci 2003; 23: 7710-8. (Pubitemid 37034089)
92. Mason JL, Ye P, Suzuki K, D'Ercole AJ, Matsushima GK. Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination. J Neurosci 2000; 20: 5703-8. (Pubitemid 30636897)
93. Masters BA, Werner H, Roberts CT Jr, LeRoith D, Raizada MK. Insulin-like growth factor I (IGF-I) receptors and IGF-I action in oligodendrocytes from rat brains. Regul Pept 1991; 33: 117-31.
94. McCarthy KD, de Vellis J. Preparation of separate astroglial and oligo-dendroglial cell cultures from rat cerebral tissue. J Cell Biol 1980; 85: 890-902. (Pubitemid 10007455)
95. Mekki-Dauriac S, Agius E, Kan P, Cochard P. Bone morphogenetic proteins negatively control oligodendrocyte precursor specification in the chick spinal cord. Development 2002; 129: 5117-30. (Pubitemid 35460676)
96. Mi S, Hu B, Hahm K, Luo Y, Kam Hui ES, Yuan Q, et al. LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nat Med 2007; 13: 1228-33. (Pubitemid 47530642)
97. Mi S, Lee X, Shao Z, Thill G, Ji B, Relton J, et al. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci 2004; 7: 221-8. (Pubitemid 38280445)
98. Mi S, Miller RH, Lee X, Scott ML, Shulag-Morskaya S, Shao Z, et al. LINGO-1 negatively regulates myelination by oligodendrocytes. Nat Neurosci 2005; 8: 745-51. (Pubitemid 43085840)
99. Mi S, Miller RH, Tang W, Lee X, Hu B, Wu W, et al. Promotion of central nervous system remyelination by induced differentiation of oligo-dendrocyte precursor cells. Ann Neurol 2009; 65: 304-15.
100. Miller DJ, Asakura K, Rodriguez M. Central nervous system remyelination clinical application of basic neuroscience principles. Brain Pathol 1996; 6: 331-44. (Pubitemid 26246387)
101. Miller RH, Mi S. Dissecting demyelination. Nat Neurosci 2007; 10: 1351-4. (Pubitemid 350014684)
102. Mix E, Meyer-Rienecker H, Hartung HP, Zettl UK. Animal models of multiple sclerosis-Potentials and limitations. Prog Neurobiol 2010. Epub 2010 Jun 15.
103. Mycko MP, Papoian R, Boschert U, Raine CS, Selmaj KW. Microarray gene expression profiling of chronic active and inactive lesions in multiple sclerosis. Clin Neurol Neurosurg 2004; 106: 223-9. (Pubitemid 38716150)
104. Nakahara J, Kanekura K, Nawa M, Aiso S, Suzuki N. Abnormal expression of TIP30 and arrested nucleocytoplasmic transport within oligo-dendrocyte precursor cells in multiple sclerosis. J Clin Invest 2009; 119: 169-81.
105. Nakashima K, Yanagisawa M, Arakawa H, Kimura N, Hisatsune T, Kawabata M, et al. Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. Science 1999; 284: 479-82. (Pubitemid 29289619)
106. Neumann H, Kotter MR, Franklin RJM. Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 2009; 132(Pt 2): 288-95.
107. Nguyen T, Mehta NR, Conant K, Kim KJ, Jones M, Calabresi PA, et al. Axonal protective effects of the myelin-associated glycoprotein. J Neurosci 2009; 29: 630-7.
108. O'Leary MT, Hinks GL, Franklin RJM. Increasing local levels of IGF-1 mRNA expression using adenoviral vectors does not alter oligodendro-cyte remyelination in the CNS of aged rats Charlton. Mol Cell Neurosci 2002; 19: 32-42. (Pubitemid 34113695)
109. Ozawa K, Suchanek G, Breitschopf H, Bruck W, Budka H, Jellinger K, et al. Patterns of oligodendroglia pathology in multiple sclerosis. Brain 1994; 117 (Pt 6): 1311-22.
110. Panitch HS, Hirsch RL, Haley AS, Johnson KP. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1987; 1: 893-5.
111. Pasterkamp RJ, De Winter F, Holtmaat AJ, Verhaagen J. Evidence for a role of the chemorepellent semaphorin III and its receptor neuropilin-1 in the regeneration of primary olfactory axons. J Neurosci 1998; 18: 9962-76. (Pubitemid 28543772)
112. Patani R, Balaratnam M, Vora A, Reynolds R. Remyelination can be extensive in multiple sclerosis despite a long disease course. Neuropathol Appl Neurobiol 2007; 33: 277-87. (Pubitemid 46701044)
113. Patrikios P, Stadelmann C, Kutzelnigg A, Rauschka H, Schmidbauer M, Laursen H, et al. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 2006; 129: 3165-72. (Pubitemid 44871433)
114. Paz Soldan MM, Warrington AE, Bieber AJ, Ciric B, Van Keulen V, Pease LR, et al. Remyelination-promoting antibodies activate distinct Ca2+ influx pathways in astrocytes and oligodendrocytes: relationship to the mechanism of myelin repair. Mol Cell Neurosci 2003; 22: 14-24. (Pubitemid 36269112)
115. Penderis J, Shields SA, Franklin RJM. Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system. Brain 2003; 126(Pt 6): 1382-91. (Pubitemid 36644383)
116. Pfeiffer SE, Warrington AE, Bansal R. The oligodendrocyte and its many cellular processes. Trends Cell Biol 1993; 3: 191-7. (Pubitemid 23156606)
117. Popko B. Notch signaling: a rheostat regulating oligodendrocyte differentiation? Dev Cell 2003; 5: 668-9. (Pubitemid 37368853)
118. Prineas JW, Barnard RO, Revesz T, Kwon EE, Sharer L, Cho ES. Multiple sclerosis. Pathology of recurrent lesions. Brain 1993; 116 (Pt 3): 681-93. (Pubitemid 23203644)
119. Prineas JW, Connell F. Remyelination in multiple sclerosis. Ann Neurol 1979; 5: 22-31. (Pubitemid 9083248)
120. Prineas JW, Kwon EE, Cho ES, Sharer LR, Barnett MH, Oleszak EL, et al. Immunopathology of secondary-progressive multiple sclerosis. Ann Neurol 2001; 50: 646-57. (Pubitemid 33021923)
121. Raine CS, Wu E. Multiple sclerosis: remyelination in acute lesions. J Neuropathol Exp Neurol 1993; 52: 199-204. (Pubitemid 23136018)
122. Relvas JB, Setzu A, Baron W, Buttery PC, LaFlamme SE, Franklin RJM, et al. Expression of dominant-negative and chimeric subunits reveals an essential role for beta1 integrin during myelination. Curr Biol 2001; 11: 1039-43. (Pubitemid 32632718)
123. Ricard D, Rogemond V, Charrier E, Aguera M, Bagnard D, Belin MF, et al. Isolation and expression pattern of human Unc-33-like phospho-protein 6/collapsin response mediator protein 5 (Ulip6/CRMP5): coexistence with Ulip2/CRMP2 in Sema3a- sensitive oligodendrocytes. J Neurosci 2001; 21: 7203-14. (Pubitemid 32846968)
124. Rivers LE, Young KM, Rizzi M, Jamen F, Psachoulia K, Wade A, et al. PDGFRA/NG2 glia generate myelinating oligodendrocytes and piri-form projection neurons in adult mice. Nat Neurosci 2008; 11: 1392-401.
125. Robinson S, Miller RH. Contact with central nervous system myelin inhibits oligodendrocyte progenitor maturation. Dev Biol 1999; 216: 359-68.
126. Sabo JK, Kilpatrick TJ, Cate HS. Effects of bone morphogenic proteins on neural precursor cells and regulation during central nervous system injury. Neurosignals 2009; 17: 255-64.
127. Samanta J, Kessler JA. Interactions between ID and OLIG proteins mediate the inhibitory effects of BMP4 on oligodendroglial differentiation. Development 2004; 131: 4131-42. (Pubitemid 39276185)
128. See J, Mamontov P, Ahn K, Wine-Lee L, Crenshaw EB 3rd, Grinspan JB. BMP signaling mutant mice exhibit glial cell maturation defects. Mol Cell Neurosci 2007; 35: 171-82. (Pubitemid 46636308)
129. Seifert T, Bauer J, Weissert R, Fazekas F, Storch MK. Notch1 and its ligand Jagged1 are present in remyelination in a T-cell- and antibody-mediated model of inflammatory demyelination. Acta Neuropathol 2007; 113: 195-203. (Pubitemid 46158152)
130. Setoguchi T, Kondo T. Nuclear export of OLIG2 in neural stem cells is essential for ciliary neurotrophic factor-induced astrocyte differentiation. J Cell Biol 2004; 166: 963-8. (Pubitemid 39304759)
131. Shen S, Li J, Casaccia-Bonnefil P. Histone modifications affect timing of oligodendrocyte progenitor differentiation in the developing rat brain. J Cell Biol 2005; 169: 577-89. (Pubitemid 41002851)
132. Shields SA, Gilson JM, Blakemore WF, Franklin RJM. Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin-induced CNS demyelination. Glia 1999; 28: 77-83. (Pubitemid 29475582)
133. Sim FJ, Zhao C, Penderis J, Franklin RJM. The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation. J Neurosci 2002; 22: 2451-9. (Pubitemid 37465793)
134. Sobel RA, Chen M, Maeda A, Hinojoza JR. Vitronectin and integrin vitronectin receptor localization in multiple sclerosis lesions. J Neuropathol Exp Neurol 1995; 54: 202-13.
135. Spassky N, de Castro F, Le Bras B, Heydon K, Queraud-LeSaux F, Bloch-Gallego E, et al. Directional guidance of oligodendroglial migration by class 3 semaphorins and netrin-1. J Neurosci 2002; 22: 5992-6004. (Pubitemid 35387643)
136. Squire LR, Bloom FE, McConnel SK, Roberts JL, Spitzer NC, Zigmond M. Fundamental neuroscience. In: Squire LR, editor. San Diego: Elsevier; 2003. p. 61-70.
137. Stangel M, Hartung HP. Remyelinating strategies for the treatment of multiple sclerosis. Prog Neurobiol 2002; 68: 361-76. (Pubitemid 36071512)
138. Steinhauser C, Gallo V. News on glutamate receptors in glial cells. Trends Neurosci 1996; 19: 339-45. (Pubitemid 26349063)
139. Stidworthy MF, Genoud S, Li WW, Leone DP, Mantei N, Suter U, et al. Notch1 and Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination. Brain 2004; 127(Pt 9): 1928-41. (Pubitemid 39150252)
140. Sussman CR, Davies JE, Miller RH. Extracellular and intracellular regulation of oligodendrocyte development: roles of Sonic hedgehog and expression of E proteins. Glia 2002; 40: 55-64. (Pubitemid 35181343)
141. Syed YA, Baer AS, Lubec G, Hoeger H, Widhalm G, Kotter MR. Inhibition of oligodendrocyte precursor cell differentiation by myelin-associated proteins. Neurosurg Focus 2008; 24: E5.
142. Syed YA, Hand E, Mö bius W, Zhao C, Hofer M, Nave KA, et al. Inhibition of CNS remyelination by the presence of Semaphorin 3A. J Neurosci 2010.
143. Takao T, Flint N, Lee L, Ying X, Merrill J, Chandross KJ. 17beta-estradiol protects oligodendrocytes from cytotoxicity induced cell death. J Neurochem 2004; 89: 660-73. (Pubitemid 38534152)
144. Talbott JF, Cao Q, Enzmann GU, Benton RL, Achim V, Cheng XX, et al. Schwann cell-like differentiation by adult oligodendrocyte precursor cells following engraftment into the demyelinated spinal cord is BMP-dependent. Glia 2006; 54: 147-59. (Pubitemid 44230852)
145. Tatsumi K, Haga S, Matsuyoshi H, Inoue M, Manabe T, Makinodan M, et al. Characterization of cells with proliferative activity after a brain injury. Neurochem Int 2005; 46: 381-9. (Pubitemid 40292718)
146. Tiwari-Woodruff S, Morales LB, Lee R, Voskuhl RR. Differential neuro-protective and antiinflammatory effects of estrogen receptor (ER)alpha and ERbeta ligand treatment. Proc Natl Acad Sci USA 2007; 104: 14813-8. (Pubitemid 350003225)
147. Wang S, Sdrulla AD, diSibio G, Bush G, Nofziger D, Hicks C, et al. Notch receptor activation inhibits oligodendrocyte differentiation. Neuron 1998; 21: 63-75. (Pubitemid 28355692)
148. Warrington AE, Rodriguez M. Remyelination-promoting human IgMs: developing a therapeutic reagent for demyelinating disease. Curr Top Microbiol Immunol 2008; 318: 213-39.
149. Williams A, Piaton G, Aigrot MS, Belhadi A, Theaudin M, Petermann F, et al. Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis? Brain 2007; 130 (Pt 10): 2554-65. (Pubitemid 47511713)
150. Wolswijk G. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J Neurosci 1998; 18: 601-9. (Pubitemid 28041896)
151. Wolswijk G. Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis. Brain 2000; 123(Pt 1): 105-15. (Pubitemid 30037973)
152. Wolswijk G. Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain 2002; 125(Pt 2): 338-49. (Pubitemid 34127436)
153. Wong ST, Henley JR, Kanning KC, Huang KH, Bothwell M, Poo MM. A p75(NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein. Nat Neurosci 2002; 5: 1302-8. (Pubitemid 35417765)
154. Woodruff RH, Franklin RJM. The expression of myelin protein mRNAs during remyelination of lysolecithin-induced demyelination. Neuropathol Appl Neurobiol 1999; 25: 226-35. (Pubitemid 29313227)
155. Woodruff RA, Fruttiger M, Richardson WD, Franklin RJM. Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelin-ation. Mol Cell Neurosci 2004; 25: 252-62. (Pubitemid 38344108)
156. Wright BR, Warrington AE, Edberg DD, Rodriguez M. Cellular mechanisms of central nervous system repair by natural autoreactive monoclonal antibodies. Arch Neurol 2009; 66: 1456-9.
157. Ye P, D'Ercole AJ. Insulin-like growth factor I protects oligodendrocytes from tumor necrosis factor-alpha-induced injury. Endocrinology 1999; 140: 3063-72. (Pubitemid 30650620)
158. Young KM, Mitsumori T, Pringle N, Grist M, Kessaris N, Richardson WD. An Fgfr3-iCreER(T2) transgenic mouse line for studies of neural stem cells and astrocytes. Glia 2010; 58: 943-53.
159. Zawadzka M, Rivers LE, Fancy SP, Zhao C, Tripathi R, Jamen F, et al. CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination. Cell Stem Cell 2009; 6: 578-90.
160. Zhang Y, Argaw AT, Gurfein BT, Zameer A, Snyder BJ, Ge C, et al. Notch1 signaling plays a role in regulating precursor differentiation during CNS remyelination. Proc Natl Acad Sci USA 2009; 106: 19162-7.
161. Zhang Z, Cerghet M, Mullins C, Williamson M, Bessert D, Skoff R. Comparison of in vivo and in vitro subcellular localization of estrogen receptors alpha and beta in oligodendrocytes. J Neurochem 2004; 89: 674-84. (Pubitemid 38534153)
162. Zhou Y, Gunput RA, Pasterkamp RJ. Semaphorin signaling: progress made and promises ahead. Trends Biochem Sci 2008; 33: 161-70.
163. Zhu X, Bergles DE, Nishiyama A. NG2 cells generate both oligo-dendrocytes and gray matter astrocytes. Development 2008a; 135: 145-57. (Pubitemid 351201488)
164. Zhu X, Hill RA, Nishiyama A. NG2 cells generate oligodendrocytes and gray matter astrocytes in the spinal cord. Neuron Glia Biol 2008b; 4: 19-26.